View by Specialty

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 18, 2024
3 min read
Save

New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women

New data ‘offer some hope’ that checkpoint inhibitors may be safe for pregnant women

Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.

SPONSORED CONTENT
April 18, 2024
2 min read
Save

Pathogenic variants tied to second primary breast cancer diagnosis risk for young survivors

Pathogenic variants tied to second primary breast cancer diagnosis risk for young survivors

Breast cancer survivors aged 40 years or younger without pathogenic variants had a low second primary breast cancer diagnosis risk in the first 10 years after initial cancer diagnosis, researchers reported in JAMA Oncology.

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

SPONSORED CONTENT
April 17, 2024
3 min read
Save

Cancer surgery reimbursements experience ‘immense’ decline over last 2 decades

Cancer surgery reimbursements experience ‘immense’ decline over last 2 decades

The Medicare reimbursement rate for 10 common breast cancer-related surgical operations failed to outpace inflation over the last 20 years, according to a presentation at American Society of Breast Surgeons Annual Meeting.

SPONSORED CONTENT
April 11, 2024
2 min read
Save

Next-generation PARP inhibitor shows clinical benefit in certain patients with breast cancer

Next-generation PARP inhibitor shows clinical benefit in certain patients with breast cancer

Saruparib conferred clinically impactful treatment outcomes among adults with breast cancer who harbor certain genetic mutations, according to data presented at American Association for Cancer Research Annual Meeting.

SPONSORED CONTENT
April 11, 2024
3 min read
Save

New data support 'potentially practice-changing' approach to sentinel lymph node biopsy

New data support 'potentially practice-changing' approach to sentinel lymph node biopsy

Sentinel lymph node biopsy may be omitted in certain patients with early-stage breast cancer, according to findings presented at American Society of Breast Surgeons Annual Meeting.

SPONSORED CONTENT
April 10, 2024
3 min read
Save

AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer

AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer

An artificial intelligence-driven algorithm used a novel liquid biopsy assay to differentiate women with ovarian cancer from healthy patients, according to results presented at American Association for Cancer Research Annual Meeting.

SPONSORED CONTENT
April 10, 2024
3 min read
Save

CDC: Health-related social needs negatively impact access to mammography screening

CDC: Health-related social needs negatively impact access to mammography screening

Only 30% of women with health-related social needs underwent mammography screening for breast cancer in the previous 2 years, according to a newly released CDC Vital Signs report.

SPONSORED CONTENT
April 04, 2024
1 min read
Save

Fertility concerns may impact treatment decisions for young women with breast cancer

Fertility concerns may impact treatment decisions for young women with breast cancer

Many young women with newly diagnosed breast cancer have concerns regarding fertility, and these concerns may impact their treatment decisions, according to study findings published in Cancer Medicine.

SPONSORED CONTENT
April 04, 2024
2 min read
Save

Socioecological factors may mitigate racial, ethnic disparities in breast tumor biology

Socioecological factors may mitigate racial, ethnic disparities in breast tumor biology

Socioecological factors may explain the disproportionate impact of aggressive breast tumor phenotypes for racial and ethnic minority women, according to study results published in JAMA Network Open.

SPONSORED CONTENT
April 02, 2024
3 min read
Save

Prolonged use of some hormone therapies may increase risk for brain tumors

Prolonged use of some hormone therapies may increase risk for brain tumors

The prolonged use of certain progestogen hormone drugs — such as medrogestone, medroxyprogesterone acetate and promegestone — increased the risk for developing intracranial meningioma, according to data published in The BMJ.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails